Hydration Pharmaceuticals Company LimitedASX: HPC

Rights Offer - Despatch of Prospectus

· Issued by Hydration Pharmaceuticals Company Limited via ASX

Filed with ASX · · 10 pages · English

Summary by 6ix AI

Hydration Pharmaceuticals Company Limited has announced the despatch of a prospectus for its non-renounceable pro rata entitlement offer, which allows eligible shareholders to subscribe for new shares and options. The offer is available to shareholders registered as of a specific date, with the closing date set for mid-November. The company aims to raise funds for ongoing working capital requirements through this offer, which is not underwritten. Ineligible foreign shareholders will not receive the prospectus or be able to participate in the offer.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

743 Prospect Street La Jolla CA 92037 Company Announcement — ASX: HPC DATE: 2 November 2026 Rights Offer– Despatch of Prospectus Hydration solutions company The Hydration Pharmaceuticals Company Limited (ASX: HPC) ("HPC" or the "Company") confirms that the prospectus dated 23 October 2026...

Hydration Pharmaceuticals Company Limited on 6ix

Story so far

Earlier from Hydration Pharmaceuticals

All Hydration Pharmaceuticals news releases